New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	7/14/2000 9:50:30 AM
From: scaram(o)uche	Read Replies (1) of 724

trickle down rationale, just a matter of time until it hits home, IMO......... biz.yahoo.com A decent track record won't hurt, either. "I go for revenue-driven companies, not companies that are in early stages," says Paul Knight, analyst with Thomas Weisel , who recommends PerkinElmer (NYSE: PKI - news) , BioSource International (Nasdaq: BIOI - news) and Varian Medical Systems (NYSE: VAR - news) , which all make products for the biotech industry. "They have established products and distribution networks," he explains. Weisel, which rates all three stocks strong buys, advised PerkinElmer in a recent transaction but doesn't do work for the others.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next